Literature DB >> 22133027

Bacterial and viral sialidases: contribution of the conserved active site glutamate to catalysis.

Jefferson Chan1, Jacqueline N Watson, April Lu, Viviana C Cerda, Thor J Borgford, Andrew J Bennet.   

Abstract

Mutagenesis of the conserved glutamic acid of influenza type A (E277) and Micromonospora viridifaciens (E260) sialidases was performed to probe the contribution of this strictly conserved residue to catalysis. Kinetic studies of the E260D and E260C M. viridifaciens mutant enzymes reveal that the overall mechanism of action has not changed. That is, the mutants are retaining sialidases in which glycosylation and deglycosylation are rate-limiting for k(cat)/K(m) and k(cat), respectively. The solvent kinetic isotope effect and proton inventory on k(cat) for the E260C mutant sialidase provide strong evidence that the newly installed cysteine residue provides little catalytic acceleration. The results are consistent with the conserved aspartic acid residue (D92) becoming the key general acid/base residue in the catalytic cycle. In addition, the E277D mutant influenza type A sialidase is catalytically active toward 4-nitrophenyl α-D-sialoside, although no measurable hydrolysis of natural substrates was observed. Thus, mutating the glutamate residue (E277) to an aspartate increases the activation free energy of hydrolysis for natural substrates by >22 kJ/mol.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22133027     DOI: 10.1021/bi201019n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  3 in total

1.  Covalent Antiviral Agents.

Authors:  Sako Mirzaie; Fatemeh Abdi; Amin GhavamiNejad; Brian Lu; Xiao Yu Wu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Investigation of substrate specificity of sialidases with membrane mimetic glycoconjugates.

Authors:  Sonia Tomar; Xue-Long Sun
Journal:  Glycoconj J       Date:  2019-12-04       Impact factor: 2.916

3.  Influenza neuraminidase operates via a nucleophilic mechanism and can be targeted by covalent inhibitors.

Authors:  Christopher J Vavricka; Yue Liu; Hiromasa Kiyota; Nongluk Sriwilaijaroen; Jianxun Qi; Kosuke Tanaka; Yan Wu; Qing Li; Yan Li; Jinghua Yan; Yasuo Suzuki; George F Gao
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.